With a combined value of $40m for each of the two domains, the multi-year indefinite-delivery indefinite-quantity (IDIQ) contract features three-year performance period and a two-year option, and covers delivery of support services for OPETS engineering-technical and logistics domain.
Under the deal, CACI will support production and deployment of chemical and biological defence materiel for the DoD Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD).
CACI chief operating officer and US Operations president John Mengucci said: "Our extensive involvement in wide-ranging projects in the C4ISR and logistics arenas will be directly relevant in ensuring the success of the Joint Program Executive Office for Chemical and Biological Defense’s mission."
CACI president and chief executive officer Dan Allen said the company has a proven ability to rapidly deploy technology and solutions required to support the DoD’s high priority missions.
The company will specifically provide JPEO-CBD with subject matter experts on chemical and biological defence, in addition to helping with technical drawings development, configuration management, and logistics analysis and risk management, in an effort to safeguard soldiers from chemical and biological threats.
The JPEO-CBD is a joint services single focal point for advanced research, development, acquisition, deployment and lifecycle support of chemical and biological defence (CBD) and reconnaissance systems, protection and decontamination systems, information management systems and medical technology in support of DoD operations across the US and worldwide.